The clinical trials below are available in the specialty you selected. Choose a different specialty.

Do You or Your Loved One Have Memory Problems?
A phase 3 multicenter, randomized, placebo-controlled, 12-month safety and efficacy study evaluating dimebon in patients with mild-to-moderate Alzheimer’s disease on donepezil. (REF# 15701)

Double-Blind Placebo-Controlled Preliminary Study of Efficacy, Safety, and Tolerability of ST101 in Treatment of Alzheimer’s Disease in Subjects Concurrently Receiving Donepezil (Aricept®)
You or your loved one may be eligible for participation in an investigational drug study
for Alzheimer’s disease if you qualify. (REF# 15288)

Double-Blind Controlled Preliminary Study of Efficacy, Safety, and Tolerability of ST101 in Treatment of Alzheimer's Disease
You or your loved one may be eligible for participation in a new investigational drug study for Alzheimer’s disease if you meet the qualifications. (REF# 15028)

Neurobiology of Nicotine and Non-Nicotine Components of Tobacco Addiction
If you are a cigarette smoker between the ages of 18 and 55, you may be eligible for this study. (REF# 4092)

Memory and Picture Viewing Study for Non-Smokers
Non-smokers are needed for a clinical trial that examines the brain's response to memory tasks and picture viewing. (REF# 8250)

Quit Smoking
This clinical trial may give you the tools you need to quit smoking. (REF# 9639)

Healthy Volunteers Needed for Sleep Study
If you are 18 to 65 years of age, in good health, and have trouble falling asleep and/or staying asleep more than two times a week, you may qualify for a sleep research study. (REF# 9502)

Aging, Brain, and Cognition
Healthy seniors are invited to participate in research investigating how our brains process certain types of information. (REF# 3203)

NET-PD LS-1 Parkinson's Disease (PD) Study
The purpose of this study is to determine if creatine, the study drug, slows the worsening of PD over time. (REF# 9525)

Do You or a Family Member Suffer from Alzheimer's Disease?
Duke University Medical Center is conducting a research study to determine if an investigational drug is safe and effective in the treatment of mild to moderate Alzheimer's disease. (REF# 7581)

Page 1 2 of 2